Timothy P. Harrower

Exeter, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

In vivo mapping of striatal neurodegeneration in Huntington's disease with Soma and Neurite Density Imaging.

In vivo mapping of striatal neurodegeneration in Huntington's disease with Soma and Neurite Density Imaging.

Journal: eLife

Published: August 11, 2026

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial.

Journal: Health technology assessment (Winchester, England)

Published: June 29, 2026

Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.

Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial.

Journal: Lancet (London, England)

Published: March 23, 2025

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.

Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK.

Journal: BMJ open

Published: September 16, 2024

Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.

Dyspnea (breathlessness) in amyotrophic lateral sclerosis/motor neuron disease: prevalence, progression, severity, and correlates.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: March 11, 2024

Correlates and trajectories of relapses in relapsing-remitting multiple sclerosis.

Correlates and trajectories of relapses in relapsing-remitting multiple sclerosis.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 02, 2023

Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.

Prevalence of depression in amyotrophic lateral sclerosis/motor neuron disease: multi-attribute ascertainment and trajectories over 30 months.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: September 06, 2022

Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-12.

Measuring disability in amyotrophic lateral sclerosis/motor neuron disease: the WHODAS 2.0-36, WHODAS 2.0-32, and WHODAS 2.0-12.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: July 25, 2022

The impact of smoking cessation on multiple sclerosis disease progression.

The impact of smoking cessation on multiple sclerosis disease progression.

Journal: Brain : a journal of neurology

Published: June 14, 2021

Quality of life in multiple sclerosis is dominated by fatigue, disability and self-efficacy.

Quality of life in multiple sclerosis is dominated by fatigue, disability and self-efficacy.

Journal: Journal of the neurological sciences

Published: February 02, 2021

Measuring coping in people with amyotrophic lateral sclerosis using the Coping Index-ALS: A patient derived, Rasch compliant scale.

Measuring coping in people with amyotrophic lateral sclerosis using the Coping Index-ALS: A patient derived, Rasch compliant scale.

Journal: Journal of the neurological sciences

Published: August 10, 2020

Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF.

Measuring quality of life in ALS/MND: validation of the WHOQOL-BREF.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: June 27, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026